Who owns NEUROBO PHARMACEUTICALS INC?
- Ticker: MTVA
- CUSIP Number: 64132r404
Tip: Access positions for across all investors
Analyze quarterly positions in Neurobo Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Neurobo Pharmaceuticals stock
Who bought or sold NEUROBO PHARMACEUTICALS INC this quarter?
Fund or Company Name |
Shares Held |
Valued At |
Change in Shares |
As Of |
Actions |
|---|---|---|---|---|---|
| Armistice Capital | 729k | $1.5M | -14% | Dec 2024 |
|
| Vanguard Group | 61k | $123k | 0% | Dec 2024 |
|
| SG Americas Securities | 41k | $83k | 100% | Dec 2024 |
|
| Geode Capital Management | 37k | $76k | 14% | Dec 2024 |
|
| State Street Corporation | 16k | $32k | 0% | Dec 2024 |
|
| Northern Trust | 14k | $27k | 0% | Dec 2024 |
|
| BlackRock | 5.3k | $11k | 0% | Dec 2024 |
|
| Tower Research Capital | 2.2k | $4.5k | 55% | Dec 2024 |
|
| UBS Group | 1.3k | $2.6k | -90% | Dec 2024 |
|
| Spire Wealth Management | 500.00 | $1.0k | 100% | Dec 2024 |
|
| Bank of America Corporation | 30.00 | $60.999000 | 0% | Dec 2024 |
|
| Brown Brothers Harriman & Co. | 27.00 | $54.999000 | 100% | Dec 2024 |
|
| Jpmorgan Chase & Co | 7.00 | $14.000000 | 0% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 4.00 | $8.000000 | 0% | Dec 2024 |
|
| SBI Securities | 2.00 | $4.000000 | 100% | Dec 2024 |
|
Who sold out of Neurobo Pharmaceuticals?
Fund or Company Name |
Date Sold |
Shares Held |
Valued At |
|---|---|---|---|
| Affinity Asset Advisors | Sep 2024 | 89k | $283k |
| Ferguson Wellman Capital Management | Sep 2024 | 16k | $50k |